Harvard pens Astellas research deal, vowing to push on despite pandemic

With COVID-19 still sweeping across the U.S. and daily cases and deaths making for grim reading, biomedical R&D deals are not an easy sell.

Harvard pens Astellas research deal, vowing to push on despite pandemic
With COVID-19 still sweeping across the U.S. and daily cases and deaths making for grim reading, biomedical R&D deals are not an easy sell.